Resources

Resource Center

Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.

In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.

Resources

Filter

No results found

Publications

Filter

Cognitive Impairment in the Age-Related Eye Disease Study. AREDS Report No. 16

04/2006

Clemons, T., Rankin, M., McBee, W., Group, A.R.Eye Diseas

Day-to-Day Variability in Acid Reflux Patterns Using the BRAVO pH Monitoring System

01/2006

Ahlawat, S.K., Novak, D.J., Williams, D.C., Maher, K.A., Barton, F., Benjamin, S.B.

Dose-Related Safety and Immunogenicity of A Trivalent Baculovirus-Expressed Influenza-Virus Hemagglutinin Vaccine in Elderly Adults

05/2006

Treanor, J.J., Schiff, G.M., Couch, R.B., Cate, T.R., Brady, R.C., Hay, C.M., Wolff, M.C., She, D., Cox, M.J.C.

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA-and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing [...] Epitopes

05/2006

Goonetilleke, N., Moore, S., Dally, L., Winstone, N., Cebere, I., Mahmoud, A., Pinheiro, S., Gillespie, G., Brown, D., Loach, V., Roberts, J., Guimar-Walker, A., Hayes, P., Loughran, K., Smith, C., DeBont, J., Verlinde, C., Vooijs, D., Schmidt, C., McMichael, A.[...]

Phase I Clinical Trial Safety of DNA- and Modified Virus Ankara-Vectored Human Immunodeficiency Virus Type 1 (HIV-1) Vaccines Administered Alone and in a Prime-Boost Regime to healthy HIV-1 Uninfected Volunteers

01/2006

Cebere, I., Dorrell, L., McShane, H., Simmons, A., McCormack, S., Schmidt, C., Smith, C., Brooks, M., Roberts, J.E., Darwin, S.C., Fast, P.E., Conlon, C., Rowland-Jones, S., McMichael, A.J., Hanke, T.

Phase II Trial of Celecoxib and Photodynamic Therapy (C-PDT) for Neovascular Age-Related Macular Degeneration

23/02/2005

Csaky, K., Blodi, B., Osman, M., Fullmer, K., Callanan, D., Cousins, S.